Ripanda, A.Luanda, A.Sule, K. S.Mtabazi, G. S.Makangara, J. J.2023-05-252023-05-252023Ripanda, A., Luanda, A., Sule, K. S., Mtabazi, G. S., & Makangara, J. J. (2023). Galinsoga parviflora (Cav.): A comprehensive review on ethnomedicinal, phytochemical and pharmacological studies. HeliyonURL: https://www.cell.com/action/showPdf?pii=S2405-8440%2823%2900724-7DOI: https://doi.org/10.1016/j.heliyon.2023.e13517http://hdl.handle.net/20.500.12661/4015Full text article. Also available at https://linkinghub.elsevier.com/retrieve/pii/S2405844023007247Galinsoga parviflora (Cav.) is a member of the Asteraceae family traditionally used for treatment of various ailments such as malaria, flu, cold, colorectal cancer, liver problems and inflammation. The medicinal properties of G. parviflora are due to the presence of various secondary metabolites including flavonoids, saponins, terpenoids and tannins. The literature survey revealed that G. parviflora possesses several pharmacological properties such as antibacterial, antifungal, antioxidant and antidiabetic. This review systematically discusses the potential of G. parviflora for managing medical conditions. The information is collected from various online databases such as Google Scholar, ScienceDirect, Springer, Web of Science, Plant of the World Online and PubMed. Among other information provided in this review, ethnomedicinal uses, phytochemistry and pharmacological activities are discussed extensively. Additonally, the potential benefits, challenges and future opportunities are presented.enGalinsoga parvifloraExtractsMedical conditionsMedicinal plantPharmacological propertiesCavArticle